In the past week, OGN stock has gone up by 9.42%, with a monthly gain of 15.79% and a quarterly surge of 28.93%. The volatility ratio for the week is 5.07%, and the volatility levels for the last 30 days are 3.31% for Organon & Co.. The simple moving average for the past 20 days is 12.65% for OGN’s stock, with a 20.60% simple moving average for the past 200 days.
Is It Worth Investing in Organon & Co. (NYSE: OGN) Right Now?
Organon & Co. (NYSE: OGN) has a price-to-earnings ratio of 5.07x that is above its average ratio. Additionally, the 36-month beta value for OGN is 0.78. There are mixed opinions on the stock, with 0 analysts rating it as a “buy,” 0 rating it as “overweight,” 0 rating it as “hold,” and 0 rating it as “sell.”
The public float for OGN is 255.16M and currently, short sellers hold a 4.29% ratio of that float. The average trading volume of OGN on May 07, 2024 was 2.39M shares.
OGN) stock’s latest price update
Organon & Co. (NYSE: OGN) has experienced a rise in its stock price by 5.46 compared to its previous closing price of 19.61. However, the company has seen a gain of 9.42% in its stock price over the last five trading days. Zacks Investment Research reported 2024-05-02 that Organon (OGN) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Analysts’ Opinion of OGN
Many brokerage firms have already submitted their reports for OGN stocks, with Goldman repeating the rating for OGN by listing it as a “Neutral.” The predicted price for OGN in the upcoming period, according to Goldman is $16 based on the research report published on November 03, 2023 of the previous year 2023.
Barclays, on the other hand, stated in their research note that they expect to see OGN reach a price target of $28. The rating they have provided for OGN stocks is “Overweight” according to the report published on September 21st, 2023.
Raymond James gave a rating of “Outperform” to OGN, setting the target price at $33 in the report published on March 16th of the previous year.
OGN Trading at 13.73% from the 50-Day Moving Average
After a stumble in the market that brought OGN to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -14.12% of loss for the given period.
Volatility was left at 3.31%, however, over the last 30 days, the volatility rate increased by 5.07%, as shares surge +13.88% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +11.78% upper at present.
During the last 5 trading sessions, OGN rose by +9.42%, which changed the moving average for the period of 200-days by -1.05% in comparison to the 20-day moving average, which settled at $18.48. In addition, Organon & Co. saw 43.41% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at OGN starting from Weaver Kirke, who purchase 2,720 shares at the price of $18.36 back on Feb 22 ’24. After this action, Weaver Kirke now owns 15,181 shares of Organon & Co., valued at $49,939 using the latest closing price.
Stock Fundamentals for OGN
Current profitability levels for the company are sitting at:
- 0.11 for the present operating margin
- 0.59 for the gross margin
The net margin for Organon & Co. stands at 0.16. The total capital return value is set at 0.08.
Based on Organon & Co. (OGN), the company’s capital structure generated 0.99 points at debt to capital in total, while cash flow to debt ratio is standing at 0.09. The debt to equity ratio resting at 181.54. The interest coverage ratio of the stock is 1.84.
Currently, EBITDA for the company is 1.55 billion with net debt to EBITDA at 5.56. When we switch over and look at the enterprise to sales, we see a ratio of 2.12. The receivables turnover for the company is 4.08for trailing twelve months and the total asset turnover is 0.53. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.65.
Conclusion
In conclusion, Organon & Co. (OGN) has seen better performance in recent times. Analysts have a mixed opinion on the stock, with some rating it as a “buy” and others rating it as a “hold”. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.
